Immunome (IMNM) Return on Sales: 2023-2025
Historic Return on Sales for Immunome (IMNM) over the last 1 years, with Jun 2025 value amounting to -17.84%.
- Immunome's Return on Sales rose 734.00% to -17.84% in Q2 2025 from the same period last year, while for Jun 2025 it was -17.84%, marking a year-over-year increase of 734.00%. This contributed to the annual value of -33.82% for FY2024, which is 2601.00% down from last year.
- According to the latest figures from Q2 2025, Immunome's Return on Sales is -17.84%, which was up 10.54% from -19.94% recorded in Q1 2025.
- Immunome's Return on Sales' 5-year high stood at -7.81% during Q4 2023, with a 5-year trough of -33.82% in Q4 2024.
- In the last 3 years, Immunome's Return on Sales had a median value of -19.94% in 2025 and averaged -22.10%.
- As far as peak fluctuations go, Immunome's Return on Sales plummeted by 2,601bps in 2024, and later spiked by 734bps in 2025.
- Quarterly analysis of 3 years shows Immunome's Return on Sales stood at -7.81% in 2023, then crashed by 2,601bps to -33.82% in 2024, then skyrocketed by 734bps to -17.84% in 2025.
- Its last three reported values are -17.84% in Q2 2025, -19.94% for Q1 2025, and -33.82% during Q4 2024.